Loading
Diagnosis information
Core diagnostic criteria, specifiers, differential considerations, and documentation support in one open, scan-friendly view.
All criteria are shown. No expand controls or hidden sections.
Core criterion A
Subjective complaints of restlessness after exposure to medication
Core criterion B
At least one of: fidgety movements; rocking from foot to foot; pacing; inability to sit or stand still for at least several minutes
Core criterion C
Onset of symptoms within 4 weeks of initiating or increasing dose of causative medication, or after reducing medication used to treat EPS
Consistent with [Medication-Induced Acute Akathisia] [specifier(s)]. Following recent initiation, dose increase, or formulation change of a dopamine-blocking agent or other implicated medication, there has been the development of subjective inner restlessness; a compelling urge to move; inability to remain still; motor restlessness including pacing; rocking; shifting weight; repetitive leg movements, forming an acute syndrome with onset within days to weeks of medication exposure. The presentation is further characterised by marked distress related to restlessness; worsening with inactivity; partial, transient relief with movement, consistent with an akathisic pattern. These symptoms have resulted in clinically significant distress or impairment, and the temporal relationship to medication exposure is clear with improvement following dose reduction, discontinuation, or targeted treatment.
Adapt this supplied template to the assessment. It is not a substitute for diagnostic reasoning or local documentation requirements.